The malfunction at Harvard’s brain bank has been a setback for scientists studying disorders like Huntington’s disease, Alzheimer’s and schizophrenia, but especially for those working on autism because it exposed what is emerging as the largest obstacle to progress: the shortage of high-quality autopsied brains from young people with a well-documented medical history.
